Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis

NCT01737879 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01737879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01737879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Terminated
Start date
October 31, 2012
Completion date
July 31, 2013
Enrollment
41 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

anemia